BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 10465061)

  • 21. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive drug treatment: the potential, expected and observed effects on vascular disease.
    MacMahon S
    J Hypertens Suppl; 1990 Dec; 8(7):S239-44. PubMed ID: 2151335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure in late adolescence and early incidence of coronary heart disease and stroke in the Swedish 1969 conscription cohort.
    Falkstedt D; Koupil I; Hemmingsson T
    J Hypertens; 2008 Jul; 26(7):1313-20. PubMed ID: 18551005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure and the prevention of stroke.
    MacMahon S
    J Hypertens Suppl; 1996 Dec; 14(6):S39-46. PubMed ID: 9023715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension as a risk factor for cardiovascular morbidity and mortality in an elderly German population; the prospective STEPHY II study. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly.
    Trenkwalder P; Hendricks P; Schöniger R; Rossberg J; Lydtin H; Hense HW
    Eur Heart J; 1999 Dec; 20(23):1752-6. PubMed ID: 10562484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
    Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of systolic blood pressure in determining risk for cardiovascular disease.
    Levy D
    J Hypertens Suppl; 1999 Feb; 17(1):S15-8. PubMed ID: 10340839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study.
    Thürmer HL; Lund-Larsen PG; Tverdal A
    J Hypertens; 1994 Apr; 12(4):481-90. PubMed ID: 8064174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antihypertensive therapy and prevention of hypertensive complications].
    Kiowski W; Bühler FR
    Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1125-31. PubMed ID: 2218248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hidden truth: what do the clinical trials really tell us about BP control?
    Ruilope LM
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S3-7. PubMed ID: 7562896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension in the elderly.
    Kirkendall WM; Hammond JJ
    Arch Intern Med; 1980 Sep; 140(9):1155-61. PubMed ID: 7406612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies.
    MacMahon SW; Cutler JA; Neaton JD; Furberg CD; Cohen JD; Kuller LH; Stamler J
    J Hypertens Suppl; 1986 Dec; 4(6):S14-7. PubMed ID: 3302149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are systolic/diastolic and isolated systolic hypertension risk factors for the elderly?
    Gifford RW
    Geriatrics; 1989 Oct; 44 Suppl B():10-4. PubMed ID: 2680775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension].
    Tomov I
    Vutr Boles; 1985; 24(6):39-47. PubMed ID: 3913145
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence.
    Whelton PK; Perneger TV; He J; Klag MJ
    J Hum Hypertens; 1996 Oct; 10(10):683-9. PubMed ID: 9004095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishing the effect of antihypertensive treatment on coronary morbidity and mortality.
    Wilhelmsen L
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():41-6; discussion 47. PubMed ID: 2691694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of treatment of the elderly hypertensive.
    Moser M
    Geriatrics; 1989 Oct; 44 Suppl B():30-6. PubMed ID: 2680778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.